⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Amoy Diagnostics Co., Ltd. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Amoy Diagnostics Co., Ltd.
↗Xiamen, China
Amoy Diagnostics (AmoyDx) is a leading R&D-based molecular diagnostics company dedicated to oncology precision medicine. The company develops, manufactures, and distributes a comprehensive portfolio of diagnostic assays, including single-gene testing kits, multi-gene panels, and NGS-based solutions, to support personalized cancer treatment.
Founded in 2008, the company is headquartered in Xiamen, China, and has established a strong global presence through partnerships with major pharmaceutical companies. Its proprietary technologies, such as ADx-ARMS and Super-ARMS, are widely used to detect genetic mutations and biomarkers, enabling clinicians to make informed decisions for patients with various solid tumors and blood cancers.
CLASSIFICATION
Company Type:Diagnostics
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Molecular Diagnostics / Oncology
SIZE & FINANCIALS
Employees:1001-5000
Founded:2008
Ownership:public
Status:operating
STOCK
Exchange:SZSE
Ticker:300685
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Diagnostic Company)
Modalities:Molecular Diagnostics, NGS, PCR, IHC, FISH
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:AstraZeneca (Lung cancer CDx), Merck KGaA (MET inhibitor CDx), Servier (Glioma CDx), Amgen (Lung cancer CDx), Pierre Fabre
COMPETITION
Position:Leader
Competitors:Labcorp, Thermo Fisher Scientific, Danaher, Qiagen
LEADERSHIP
Key Executives:
Zheng Limou - Founder and CEO
Scientific Founders:Zheng Limou
LINKS
Website:amoydiagnostics.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Amoy Diagnostics Co., Ltd.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.